2024 annual financial data
Vaxcyte 2024 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -569,546,000 USD and net income was -463,927,000 USD.
Operating cash flow was -452,627,000 USD.
Get free Vaxcyte email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -569,546,000 USD
- Net income
- -463,927,000 USD
- Operating cash flow
- -452,627,000 USD